接受依维莫司治疗的转移性空肠神经内分泌肿瘤新冠阳性男性患者对聚乙二醇化干扰素的反应
Response to pegylated interferon in a COVID-19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus.
作者信息
Frankel Arthur E, Yip Wai C, Naik Eknath, Hasselbalch Hans C
机构信息
Department of Medicine West Palm Beach VA Medical Center West Palm Beach FL USA.
Department of Hematology Zealand University Hospital Roskilde Denmark.
出版信息
Clin Case Rep. 2021 Jun 9;9(6):e04218. doi: 10.1002/ccr3.4218. eCollection 2021 Jun.
Abstract
A 61-year-old male on everolimus had chronic SARS-CoV-2 infection. Addition of pegylated interferon cleared viral RNA and supports combination therapy with everolimus plus interferon for COVID-19.
摘要
一名正在服用依维莫司的61岁男性患有慢性严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染。添加聚乙二醇化干扰素清除了病毒RNA，并支持依维莫司联合干扰素用于治疗2019冠状病毒病（COVID-19）的联合疗法。
相似文献
1
Response to pegylated interferon in a COVID-19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus.接受依维莫司治疗的转移性空肠神经内分泌肿瘤新冠阳性男性患者对聚乙二醇化干扰素的反应
Clin Case Rep. 2021 Jun 9;9(6):e04218. doi: 10.1002/ccr3.4218. eCollection 2021 Jun.
2
Response to pegylated interferon in a COVID-19-positive elderly woman with primary myelofibrosis treated with ruxolitinib.一名接受芦可替尼治疗的原发性骨髓纤维化的新冠病毒阳性老年女性对聚乙二醇化干扰素的反应。
Clin Case Rep. 2021 Mar 7;9(4):2228-2235. doi: 10.1002/ccr3.3997. eCollection 2021 Apr.
3
Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.聚乙二醇化干扰素α-2a和α-2b联合利巴韦林治疗慢性丙型肝炎：系统评价与经济学评估
Health Technol Assess. 2004 Oct;8(39):iii-iv, 1-125. doi: 10.3310/hta8390.
4
Pegylated interferon alfa and ribavirin for children with chronic hepatitis C.聚乙二醇干扰素α和利巴韦林治疗儿童慢性丙型肝炎。
World J Gastroenterol. 2013 Feb 21;19(7):1098-103. doi: 10.3748/wjg.v19.i7.1098.
5
The sustained virologic response of nonresponder hepatitis C virus patients with retreatment.经再次治疗的无反应性丙型肝炎病毒患者的持续病毒学应答
Indian J Pathol Microbiol. 2011 Jan-Mar;54(1):81-4. doi: 10.4103/0377-4929.77330.
6
Early Treatment with Pegylated Interferon Lambda for Covid-19.聚乙二醇干扰素 λ 早期治疗 COVID-19。
N Engl J Med. 2023 Feb 9;388(6):518-528. doi: 10.1056/NEJMoa2209760.
7
Case Report of COVID-19 Infection After Kidney Transplant Treated With Casirivimab-Imdevimab and Mycophenolate Mofetil Changed to Everolimus.COVID-19 感染病例报告：肾移植后接受卡司瑞韦单抗-伊德韦单抗治疗，并将霉酚酸酯转换为依维莫司。
Transplant Proc. 2022 Jul-Aug;54(6):1561-1563. doi: 10.1016/j.transproceed.2021.12.018. Epub 2021 Dec 31.
8
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study.依维莫司联合奥曲肽长效缓释剂治疗与类癌综合征相关的晚期神经内分泌肿瘤（RADIANT-2）：一项随机、安慰剂对照、3 期研究。
Lancet. 2011 Dec 10;378(9808):2005-2012. doi: 10.1016/S0140-6736(11)61742-X. Epub 2011 Nov 25.
9
Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin.利巴韦林对1型丙型肝炎患者接受聚乙二醇化干扰素α-2a加利巴韦林治疗反应的影响。
Gastroenterology. 2006 Oct;131(4):1040-8. doi: 10.1053/j.gastro.2006.07.022. Epub 2006 Jul 24.
10
Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype-4 chronic hepatitis C patients.羟氯喹增强4型慢性丙型肝炎患者对聚乙二醇化干扰素加利巴韦林的早期病毒学应答。
J Med Virol. 2016 Dec;88(12):2170-2178. doi: 10.1002/jmv.24575. Epub 2016 May 25.
引用本文的文献
1
FDA-approved drugs as potential covalent inhibitors of key SARS-CoV-2 proteins: an in silico approach.经美国食品药品监督管理局批准的药物作为新型冠状病毒关键蛋白的潜在共价抑制剂：一种计算机模拟方法。
Turk J Biol. 2025 Apr 7;49(3):233-246. doi: 10.55730/1300-0152.2741. eCollection 2025.
2
Current utilization of interferon alpha for the treatment of coronavirus disease 2019: A comprehensive review.当前干扰素 α 在治疗 2019 冠状病毒病中的应用：全面综述。
Cytokine Growth Factor Rev. 2022 Feb;63:34-43. doi: 10.1016/j.cytogfr.2022.01.001. Epub 2022 Jan 13.
本文引用的文献
1
Genes with 5' terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 Nsp1 protein.带有 5' 端寡嘧啶序列的基因优先逃避 SARS-CoV-2 Nsp1 蛋白对翻译的全局抑制。
RNA. 2021 Sep;27(9):1025-1045. doi: 10.1261/rna.078661.120. Epub 2021 Jun 14.
2
Response to pegylated interferon in a COVID-19-positive elderly woman with primary myelofibrosis treated with ruxolitinib.一名接受芦可替尼治疗的原发性骨髓纤维化的新冠病毒阳性老年女性对聚乙二醇化干扰素的反应。
Clin Case Rep. 2021 Mar 7;9(4):2228-2235. doi: 10.1002/ccr3.3997. eCollection 2021 Apr.
3
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.SARS-CoV-2、SARS-CoV 和 MERS-CoV 的病毒载量动态、病毒脱落持续时间和传染性：系统评价和荟萃分析。
Lancet Microbe. 2021 Jan;2(1):e13-e22. doi: 10.1016/S2666-5247(20)30172-5. Epub 2020 Nov 19.
4
Novavax offers first evidence that COVID vaccines protect people against variants.诺瓦瓦克斯公司提供了首个证据，证明新冠疫苗可保护人们抵御病毒变种。
Nature. 2021 Feb;590(7844):17. doi: 10.1038/d41586-021-00268-9.
5
Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19.新型冠状病毒肺炎住院患者中可培养的严重急性呼吸综合征冠状病毒2的持续时间。
N Engl J Med. 2021 Feb 18;384(7):671-673. doi: 10.1056/NEJMc2027040. Epub 2021 Jan 27.
6
Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors.胃-肠-胰神经内分泌肿瘤的分子病理学。
Endocr Pathol. 2021 Mar;32(1):169-191. doi: 10.1007/s12022-021-09662-5. Epub 2021 Jan 18.
7
Complete recovery from COVID-19 of a kidney-pancreas transplant recipient: potential benefit from everolimus?COVID-19 康复：依维莫司对肾胰联合移植受者的潜在获益？
BMJ Case Rep. 2021 Jan 11;14(1):e238413. doi: 10.1136/bcr-2020-238413.
8
The SARS-CoV-2 RNA-protein interactome in infected human cells.感染人类细胞中的 SARS-CoV-2 RNA-蛋白相互作用组。
Nat Microbiol. 2021 Mar;6(3):339-353. doi: 10.1038/s41564-020-00846-z. Epub 2020 Dec 21.
9
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.REGN-COV2，一种中和抗体鸡尾酒疗法，用于治疗门诊新冠患者。
N Engl J Med. 2021 Jan 21;384(3):238-251. doi: 10.1056/NEJMoa2035002. Epub 2020 Dec 17.
10
Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection.用于预防严重急性呼吸综合征冠状病毒 2 感染的临床开发疫苗制剂。
Adv Drug Deliv Rev. 2021 Feb;169:168-189. doi: 10.1016/j.addr.2020.12.006. Epub 2020 Dec 13.
Zotero 插件